CTNM News
Contineum Therapeutics, Inc. Class A Common Stock
$7.83
-$0.31(-3.81%)
46
Overall
60
Value
45
Tech
34
Quality
Market Cap
$306.24M
Volume
313.28K
52W Range
$8.60 - $17.79
Target Price
$21.83
CTNM news: the latest Contineum Therapeutics, Inc. Class A Common Stock headlines, press releases and market updates, newest first.
Latest CTNM News
- Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from JonesTradingTipRanks Auto-Generated Intelligence Newsdesk · Sep 27, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Sep 23, 2026
- RBC Capital Sticks to Their Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)TipRanks Auto-Generated Intelligence Newsdesk · Sep 22, 2026
- Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Recursion Pharmaceuticals (RXRX) and Contineum Therapeutics, Inc. Class A (CTNM)TipRanks Newsroom · Sep 21, 2026
- Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)TipRanks Newsroom · Sep 19, 2026
- Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from Leerink PartnersTipRanks Auto-Generated Intelligence Newsdesk · Sep 16, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $7.83 | -3.8% | 313.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics, Inc. Class A Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW